Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 17:24:28 GMT 2023
by
admin
on
Sat Dec 16 17:24:28 GMT 2023
|
Protein Type | MONOCLONAL ANTIBODY |
Protein Sub Type | FAB2 |
Sequence Origin | HUMANIZED MOUSE |
Sequence Type | COMPLETE |
Record UNII |
X77RS4CMJF
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
211323-03-4
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
8076
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
LL-50
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109095
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
X77RS4CMJF
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
Erlizumab
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY | |||
|
C169959
Created by
admin on Sat Dec 16 17:24:28 GMT 2023 , Edited by admin on Sat Dec 16 17:24:28 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_151 | 1_207 |
1_227 | 3_214 |
1_236 | 2_236 |
2_22 | 2_96 |
2_151 | 2_207 |
2_227 | 4_214 |
3_23 | 3_88 |
3_134 | 3_194 |
4_23 | 4_88 |
4_134 | 4_194 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:ESTIMATE | CHEMICAL |
|